Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial

Overview of attention for article published in Liver Transplantation, March 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#22 of 3,803)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 7 news outlets
policy: 1 policy source
twitter: 9 X users
patent: 6 patents

facebook: 1 Facebook page
wikipedia: 3 Wikipedia pages
guideline: 3 clinical guideline sources

Readers on

mendeley: 120 Mendeley

So far, Altmetric has seen 7 news stories from 7 outlets.

Vital Therapies Announces Fourth Quarter and Full Year 2017 Financial Results

BioTech Gate, 13 Mar 2018

- VTL-308 Enrollment Nears Completion with 147 Subjects Enrolled as of March 12 - On Track for Release of Topline Results in…

Vital Therapies Announces Fourth Quarter and Full Year 2017 Financial Results

Biz Wire Express, 13 Mar 2018

GlobeNewswire 2018-03-13 - VTL-308 Enrollment Nears Completion with 147 Subjects Enrolled as of March 12 - On Track for Release…

Vital Therapies Announces Fourth Quarter and Full Year 2017 Financial Results

Benzinga, 13 Mar 2018

- VTL-308 Enrollment Nears Completion with 147 Subjects Enrolled as of March 12 - On Track for Release of Topline Results in…

Vital Therapies Announces Fourth Quarter and Full Year 2017 Financial Results

TMCnet.com, 13 Mar 2018

- VTL-308 Enrollment Nears Completion with 147 Subjects Enrolled as of March 12 - On Track for Release of Topline Results in…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 3 additional news stories.